Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Vektor Medical has announced that use of its vMap arrhythmia mapping system during complex atrial fibrillation (AF) ablation was associated with significantly improved freedom from atrial arrhythmias compared with standard-of-care pulmonary vein isolation.

News | Atrial Fibrillation

New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study

March 30, 2023 —Vektor Medical has announced that use of its vMap arrhythmia mapping system during complex atrial ...

March 30, 2023

The breakthrough findings solve a known problem for scientists working on cellular reprogramming, one of the most promising areas of regenerative medicine

News | Heart Failure

Heart Attack Study Could Change the Game in Regenerative Medicine

March 30, 2023 — Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to ...

March 30, 2023

A joint team of researchers from POSTECH and Georgia Institute of Technology successfully created an engineered heart via 3D printing technology that allows for early monitoring of drug-induced cardiotoxicity

News | Medical 3-D Printing

In Vitro 3D Engineered Heart Tissue that Monitors Drug-induced Cardiotoxicity

March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics ...

March 29, 2023

News | Cardiovascular Clinical Studies

Multi-Ethnic Study of Atherosclerosis Sheds Light on Sleep Irregularity and Cardiovascular Disease

March 29, 2023 — Irregular sleep patterns may play a role in the pathophysiologic development of cardiovascular disease ...

March 29, 2023

PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030

News | Cardiovascular Clinical Studies

Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

March 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

March 27, 2023

News | Cardiovascular Clinical Studies

Clinical Trial of Investigational Vaccine to Treat LDL Cholesterol Underway

March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of ...

March 24, 2023

A newly-published study in the European Society of Cardiology’s European Heart Journal is shedding new light on the obesity paradox.

News | ESC

Study Puts ‘Obesity Paradox’ in Spotlight: Waist-to-height Ratio Better Than BMI as Indicator of Outcomes in Patients with Heart Failure

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients ...

March 23, 2023

New Patent Adds to the Istaroxime Patent Estate and Provides Intellectual Property Protection Until Late 2039

News | Cardiogenic Shock

Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

March 22, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

March 22, 2023

News | Cardiovascular Clinical Studies

Clinical Science Session at THT 2023 Presents 12-month Data on AccuCinch Ventricular Restoration System for Heart Failure Patients with HFrEf

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely ...

March 22, 2023

The first platform to combine real-world cardiology data from millions of people in multiple European countries is set to advance research aimed at improving heart health

News | Cardiovascular Clinical Studies

New European Heart Disease Data Set to Advance Research Aimed at Improving Heart Healt

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European ...

March 21, 2023

Six-month results from the BIOMAG-I clinical study including intravascular imaging data were presented at CRT 2023

News | Stents Bioresorbable

New Data Highlight Promising Angiographic and Safety Profile of BIOTRONIK’s Third Generation Resorbable Magnesium Scaffold

March 16, 2023 — Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the B ...

March 16, 2023

Winners of the ACC 2023 Young Investigators Awards were announced during the American College of Cardiology Together with the World Congress of Cardiology Scientific Sessions, ACC23/WCC. The 18 finalists presenting cutting-edge science represented seven states, three countries and 11 different institutions.

News | ACC

Young Investigator Awards at ACC 2023 Scientific Sessions Recognize Cutting-Edge Science

March 16, 2023 — The American College of Cardiology (ACC) announced the winners and finalists of its 2023 Young ...

March 16, 2023

Researchers at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine published a study in the Journal of the American Society of Echocardiography showing that transesophageal echocardiography-guided transcatheter structural intervention was associated with a major complication in 3.6 percent of patients.

News | Cardiovascular Surgery

Study Shows One in 25 Patients Undergoing Transesophageal Echocardiography-guided Transcatheter Structural Cardiac Intervention Suffered a Major Complication

March 15, 2023 — Researchers at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine published ...

March 15, 2023

Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence that higher amounts can reduce long-term disability, according to a new UCLA-led study that tracked over 500 patients across 28 acute care hospitals in their first year following a stroke.

News | Stroke

Many Patients Receive Too Little Rehab Therapy Following Stroke, Study Finds

March 15, 2023 — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence ...

March 15, 2023

US hospital claims data reveals cardiogenic shock patients have an average hospital length of stay of 19.6 days making its intensive patient care cost very high

News | Cardiogenic Shock

Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime

March 15, 2023 — Windtree Therapeutics, Inc, a biotechnology company focused on advancing late-stage interventions for ...

March 15, 2023